❉ Buffybot wonderful businesses, fair prices

← back

LH Labcorp

healthcare · 2026-09-23

N/A
too hard · 54
Owner-earnings value$272.08
Price$311.54
Margin of safety -12.7%

Quality gate · 54/100

Returns on capital 2.3/30
Consistency 20.0/22
Margins / pricing power 8.4/16
Balance sheet 7.3/16
Cash conversion 10/10
Capital allocation 5.7/6

⚠ sub-hurdle returns (median roic 7% < 9%)

Median ROIC6.9%
Gross margin28.9%
Net debt / EBITDA2.8x
FCF conversion142%
Share count / yr-2.3%
Profitable years4/4

Moat & management

Owner-earnings inputs

Owner earnings (TTM)1.16B
Owner-earnings yield4.6%
Free-cash-flow yield4.6%
Growth used (normalized)5.6%
Market-implied growth (reverse DCF)8.8%
Terminal growth3.0%
Discount rate (hurdle)9.0%

Projected owner earnings

YrOwner earningsGrowthPV
11.22B 5.6%1.12B
21.28B 5.3%1.08B
31.35B 5.0%1.04B
41.41B 4.7%999.53M
51.47B 4.4%957.51M
61.53B 4.1%914.77M
71.59B 3.9%871.55M
81.65B 3.6%828.11M
91.70B 3.3%784.68M
101.76B 3.0%741.49M

Recent news

score · 8 articles

  • Stock Market Today: Dow Skids But Apple Eyes A Buy Point; Filing Says Trump Makes These Trades
  • Why Labcorp Holdings Stock Dropped Today
  • Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services
  • Premarket movers: Quest, Labcorp hit by CMS cuts
  • 2 of Wall Street’s Favorite Stocks to Target This Week and 1 Facing Challenges
  • Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029
  • 1 Mid-Cap Stock with Competitive Advantages and 2 That Underwhelm
  • 1 Profitable Stock Worth Your Attention and 2 Facing Headwinds

⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~9%/yr owner-earnings growth over 10y (reverse DCF); model credits 6%.

History

DateQualityPriceValueMoSRating
2026-09-23 54 $311.54 $272.08 -12.7% N/A
2026-08-04 53 $307.42 $283.24 -7.9% N/A
2026-07-02 53 $283.88 $279.44 -1.6% N/A
2026-06-25 53 $265.18 $279.44 +5.4% N/A
2026-06-23 53 $258.59 $279.44 +8.1% N/A